Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Radiopharmceutical Indications Should Not Be Disease Specific, CORAR Says

Executive Summary

Radiopharmaceutical indications should not be disease specific, unless a sponsor is seeking such an indication Council on Radionuclides and Radiopharmaceuticals Secretary Robert Morgan (DuPont Merck) maintained at a Feb. 27 FDA public meeting on developing regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS031802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel